Evidence map›Paper›PMID 38275577›Full record

ArticleBioengineering (Basel, Switzerland)2024

Multi-Dimensional Validation of the Integration of Syntactic and Semantic Distance Measures for Clustering Fibromyalgia Patients in the Rheumatic Monitor Big Data Study.

Ayelet Goldstein, Yuval Shahar, Michal Weisman Raymond, Hagit Peleg, Eldad Ben-Chetrit, Arie Ben-Yehuda, Erez Shalom, Chen Goldstein, Shmuel Shay Shiloh, Galit Almoznino

Registry-linked trialAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07461805 (Caracterización de Subgrupos de Personas Con Diabetes Tipo 1), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07461805 recruitingnot on this mapstarted 2025, after this paper: background citation

Caracterización de Subgrupos de Personas Con Diabetes Tipo 1: análisis de características clínicas y glucométricas Utilizando Una aproximación de Inteligencia Artificial

Typeobservational_patient_registrySponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2025 to 2028Enrolled800ConditionsType 1 Diabetes Mellitus
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ayelet GoldsteinComputer Science Department, Hadassah Academic College, Jerusalem 9101001, Israel.ORCID 0000-0003-0794-3653
Yuval ShaharMedical Informatics Research Center, Department of Software and Information Systems Engineering, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0000-0003-0328-2333
Michal Weisman RaymondMedical Informatics Research Center, Department of Software and Information Systems Engineering, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.ORCID 0009-0007-6225-0581
Hagit PelegRheumatology Unit, Hadassah Medical Center, Jerusalem 9112102, Israel.
Eldad Ben-ChetritRheumatology Unit, Hadassah Medical Center, Jerusalem 9112102, Israel.
Arie Ben-YehudaDivision of Internal Medicine, Hadassah Medical Center, Jerusalem 9112102, Israel.
Erez ShalomMedical Informatics Research Center, Department of Software and Information Systems Engineering, Ben Gurion University of the Negev, Beer Sheva 8410501, Israel.
Chen GoldsteinFaculty of Dental Medicine, Hebrew University of Jerusalem, Israel; Big Biomedical Data Research Laboratory, Dean's Office, Hadassah Medical Center, Jerusalem 91120, Israel.
Shmuel Shay ShilohFaculty of Dental Medicine, Hebrew University of Jerusalem, Israel; Big Biomedical Data Research Laboratory, Dean's Office, Hadassah Medical Center, Jerusalem 91120, Israel.
Galit AlmozninoFaculty of Dental Medicine, Hebrew University of Jerusalem, Israel; Big Biomedical Data Research Laboratory, Dean's Office, Hadassah Medical Center, Jerusalem 91120, Israel.ORCID 0000-0001-9671-0047

Funding

Israeli Ministry of Innovation, Science and Technology 3-15608
6 · The paper itself

Abstract

This study primarily aimed at developing a novel multi-dimensional methodology to discover and validate the optimal number of clusters. The secondary objective was to deploy it for the task of clustering fibromyalgia patients. We present a comprehensive methodology that includes the use of several different clustering algorithms, quality assessment using several syntactic distance measures (the Silhouette Index (SI), Calinski-Harabasz index (CHI), and Davies-Bouldin index (DBI)), stability assessment using the adjusted Rand index (ARI), and the validation of the internal semantic consistency of each clustering option via the performance of multiple clustering iterations after the repeated bagging of the data to select multiple partial data sets. Then, we perform a statistical analysis of the (clinical) semantics of the most stable clustering options using the full data set. Finally, the results are validated through a supervised machine learning (ML) model that classifies the patients back into the discovered clusters and is interpreted by calculating the Shapley additive explanations (SHAP) values of the model. Thus, we refer to our methodology as the clustering, distance measures and iterative statistical and semantic validation (CDI-SSV) methodology. We applied our method to the analysis of a comprehensive data set acquired from 1370 fibromyalgia patients. The results demonstrate that the K-means was highly robust in the syntactic and the internal consistent semantics analysis phases and was therefore followed by a semantic assessment to determine the optimal number of clusters (k), which suggested k = 3 as a more clinically meaningful solution, representing three distinct severity levels. the random forest model validated the results by classification into the discovered clusters with high accuracy (AUC: 0.994; accuracy: 0.946). SHAP analysis emphasized the clinical relevance of "functional problems" in distinguishing the most severe condition. In conclusion, the CDI-SSV methodology offers significant potential for improving the classification of complex patients. Our findings suggest a classification system for different profiles of fibromyalgia patients, which has the potential to improve clinical care, by providing clinical markers for the evidence-based personalized diagnosis, management, and prognosis of fibromyalgia patients.

Indexed as

Big Datacluster analysisfibromyalgiaK-meansmachine learning algorithmrheumatic diseases

Identifiers

PMID38275577
PMCPMC10813477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.